OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
GLP-1 Receptor Agonists Among Patients With Overweight or Obesity, Diabetes, and HFpEF on SGLT2 Inhibitors
Rushin Patel, Mark Wadid, Bhargav Makwana, et al.
JACC Heart Failure (2024) Vol. 12, Iss. 11, pp. 1814-1826
Closed Access | Times Cited: 9
Rushin Patel, Mark Wadid, Bhargav Makwana, et al.
JACC Heart Failure (2024) Vol. 12, Iss. 11, pp. 1814-1826
Closed Access | Times Cited: 9
Showing 9 citing articles:
Obesity and Cardiovascular-Kidney-Metabolic Health
Sai Nikhila Ghanta, Candace Lessey, Bhargav Makwana, et al.
Cardiology Clinics (2025)
Closed Access
Sai Nikhila Ghanta, Candace Lessey, Bhargav Makwana, et al.
Cardiology Clinics (2025)
Closed Access
Critical Appraisal of Pharmaceutical Therapy in Diabetic Cardiomyopathy—Challenges and Prospectives
Elina Khattab, Michaelia Kyriakou, Elena Leonidou, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 1, pp. 134-134
Open Access
Elina Khattab, Michaelia Kyriakou, Elena Leonidou, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 1, pp. 134-134
Open Access
Tommaso Bucci, Uazman Alam, Grégoire Fauchier, et al.
Diabetes Obesity and Metabolism (2025)
Closed Access
Combining SGLT2is, GLP1-RAs and nsMRAs in Diabetes: A Scoping Review of Current and Future Perspectives
Elisabeth B. Stougaard, Viktor Rotbain Curovic, Tine W. Hansen
Diabetes Therapy (2025)
Open Access
Elisabeth B. Stougaard, Viktor Rotbain Curovic, Tine W. Hansen
Diabetes Therapy (2025)
Open Access
Visceral obesity and HFpEF: targets and therapeutic opportunities
Yilin Li, Zhuofeng Lin, Yulin Li
Trends in Pharmacological Sciences (2025)
Closed Access
Yilin Li, Zhuofeng Lin, Yulin Li
Trends in Pharmacological Sciences (2025)
Closed Access
Pathophysiology of heart failure with preserved ejection fraction in overweight and obesity - Clinical and treatment implications
Mariana M. Rodrigues, Luiz Menezes Falcão
International Journal of Cardiology (2025), pp. 133182-133182
Closed Access
Mariana M. Rodrigues, Luiz Menezes Falcão
International Journal of Cardiology (2025), pp. 133182-133182
Closed Access
Insights into the role of obesity in Heart Failure with Preserved Ejection Fraction pathophysiology and management
Brandon Hathorn, Mark J. Haykowsky, Jaime P. Almandoz, et al.
Canadian Journal of Cardiology (2025)
Closed Access
Brandon Hathorn, Mark J. Haykowsky, Jaime P. Almandoz, et al.
Canadian Journal of Cardiology (2025)
Closed Access
Temporal prevalence and prognostic impact of diabetes mellitus and albuminuria in heart failure with preserved ejection fraction
Nousjka P.A. Vranken, Xinyu Li, Heleen Bouman, et al.
Cardiovascular Diabetology (2025) Vol. 24, Iss. 1
Open Access
Nousjka P.A. Vranken, Xinyu Li, Heleen Bouman, et al.
Cardiovascular Diabetology (2025) Vol. 24, Iss. 1
Open Access
Cardiovascular and renal effects of the combination therapy of a GLP-1 receptor agonist and an SGLT2 inhibitor in observational real-life studies
André Scheen
Diabetes & Metabolism (2024), pp. 101594-101594
Closed Access | Times Cited: 2
André Scheen
Diabetes & Metabolism (2024), pp. 101594-101594
Closed Access | Times Cited: 2
Sodium-Glucose Cotransporter 2 Inhibitors and Glucagon-Like Peptide 1 Receptor Agonists
Josephine Harrington, Darren K. McGuire, Silvio E. Inzucchi
JACC Heart Failure (2024) Vol. 12, Iss. 11, pp. 1827-1829
Closed Access
Josephine Harrington, Darren K. McGuire, Silvio E. Inzucchi
JACC Heart Failure (2024) Vol. 12, Iss. 11, pp. 1827-1829
Closed Access
